FDA pharmacologic class
Human Immunodeficiency Virus 1 Capsid Inhibitor
1 medicine is in FDA's class of human immunodeficiency virus 1 capsid inhibitors: lenacapavir (Yeztugo); 1 combination product also contains one. 0 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are human immunodeficiency virus 1 capsid inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Lenacapavir | Sunlenca, Yeztugo | none listed | n/a | No | No current entry | 0 |
| Bictegravir and lenacapavir | Bixlenvo | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)